Zoom Colonoscopy Market Global Report 2026

The zoom colonoscopy market size has grown strongly in recent years. It will grow from $1.29 billion in 2025 to $1.41 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of colorectal cancer cases globally, increasing adoption of endoscopic screening programs, growing awareness of early gastrointestinal disease detection, expansion of hospital based diagnostic infrastructure, early development of high definition imaging endoscopy systems.

The zoom colonoscopy market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to rising demand for early cancer screening and preventive diagnostics, increasing adoption of ai enabled medical imaging technologies, expansion of ambulatory surgical and diagnostic centers, growing geriatric population requiring frequent screening, advancements in minimally invasive gastrointestinal procedures. Major trends in the forecast period include rising adoption of high definition and zoom enabled endoscopy systems for early disease detection, increasing integration of ai based polyp detection in colonoscopy procedures, growing preference for minimally invasive diagnostic gastrointestinal procedures, expansion of robotic assisted endoscopy for improved precision and accuracy, rising demand for capsule and advanced visualization endoscopy technologies.

The increasing prevalence of colorectal diseases is expected to drive the growth of the zoom colonoscopy market in the coming years. Colorectal diseases are medical conditions that affect the colon and rectum, including colorectal cancer, inflammatory bowel disease, and abnormal tissue formations that require timely diagnosis and ongoing clinical monitoring. The rising prevalence of colorectal diseases is driven by unhealthy dietary patterns, especially increased consumption of processed foods and low-fiber diets, which can negatively impact digestive health and elevate the risk of conditions such as colorectal cancer, inflammatory bowel disease, and colorectal polyps. Zoom colonoscopy supports the management of colorectal diseases by providing highly magnified visualization of the colonic mucosa, enabling clinicians to identify and assess subtle precancerous lesions and early-stage abnormalities with greater precision, thereby supporting early diagnosis and more effective treatment planning. For instance, in February 2026, according to the Office for National Statistics (ONS), a UK-based government agency, 15,552 deaths were registered due to colorectal cancer in England and Wales in 2023, while the provisional figure for 2024 indicated a marginal increase to 15,553 deaths. Therefore, the increasing prevalence of colorectal diseases is contributing to the growth of the zoom colonoscopy market.

The increasing number of gastrointestinal disorder cases is expected to drive the growth of the zoom colonoscopy market in the coming years. Gastrointestinal disorders are medical conditions affecting the digestive system, including the stomach, intestines, colon, rectum, and related digestive organs, leading to symptoms such as abdominal discomfort, diarrhea, inflammation, bleeding, and changes in bowel function. The growing incidence of gastrointestinal disorders is attributed to the rising spread of infectious gastrointestinal diseases, which continues to increase pressure on healthcare systems and diagnostic services. Zoom colonoscopy supports the diagnosis and management of gastrointestinal disorders by providing enhanced visualization of gastrointestinal abnormalities, improving diagnostic precision, enabling early detection, and supporting timely treatment decisions. For instance, in July 2025, according to the Centers for Disease Control and Prevention, a US-based public health agency, norovirus GII.17 outbreaks in the United States increased from below 10% during the 2022-23 season to nearly 75% during the 2024-25 season, surpassing GII.4 outbreaks and emphasizing the rising burden of gastrointestinal infections. Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the zoom colonoscopy market.

The expansion of healthcare facilities is expected to drive the growth of the zoom colonoscopy market in the coming years. Healthcare facilities include hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers that provide medical infrastructure and healthcare services for patient care, diagnosis, and disease management. The expansion of healthcare facilities is increasing due to higher investments in healthcare infrastructure and the growing need for specialized diagnostic services. Zoom colonoscopy supports the expansion of healthcare facilities by allowing healthcare providers to deliver advanced colorectal screening procedures, enhance diagnostic efficiency, and improve early disease detection capabilities. For instance, in January 2024, according to the American Hospital Association, a US-based healthcare association, the total number of hospitals in the United States increased from 6,093 in fiscal year 2022 to 6,120 in fiscal year 2024. Therefore, the expansion of healthcare facilities is supporting the growth of the zoom colonoscopy market.

Major companies operating in the zoom colonoscopy market report are Ambu A/S, Boston Scientific Corporation, EndoFresh Medical Co. Ltd., FUJIFILM Holdings Corporation, HOYA Corporation, Huger Medical Instrument Co. Ltd., KARL STORZ SE & Co. KG, Medtronic Public Limited Company, Olympus Corporation, Ottomed Endoscopy India Private Limited, Shanghai Aohua Photoelectricity Endoscope Co. Ltd., Shenzhen HugeMed Medical Technical Development Co. Ltd., SMART Medical Systems Ltd., SonoScape Medical Corp., Waycen Inc., Wision AI Co. Ltd., Zhuhai Seesheen Medical Technology Co. Ltd.

North America was the dominating region in the zoom colonoscopy market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the zoom colonoscopy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the zoom colonoscopy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The zoom colonoscopy market includes revenues earned by entities by services such as advanced colonoscopy imaging services, magnification endoscopy services, colorectal screening services, and endoscopic visualization services. The market value includes the value of related goods sold by the service provider or included within the service offering. The zoom colonoscopy market also includes sales of high-definition zoom colonoscopes, magnification endoscopy systems, and related accessories. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

This product will be delivered within 3-5 business days.